×
For best experience we recommend to activate Javascript in your browser.
Recombinant PCSK9 (Evolocumab Biosimilar) antibody
This Human Monoclonal antibody specifically detects PCSK9 (Evolocumab Biosimilar) in ELISA, FACS, BLI, Func and SPR. It exhibits reactivity toward Human.
Catalog No. ABIN7675956
$294.23
$346.15
save $51.92 (-15 %)
Plus shipping costs $50.00
1 mg ABIN7581603
100 μg ABIN7675956
1 mg ABIN7581603
100 μg ABIN7675956
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant PCSK9 (Evolocumab Biosimilar) antibody (ABIN7675956)
Target
PCSK9 (Evolocumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for PCSK9 (Evolocumab Biosimilar) antibodies
Human
Clonality
All clonalities for PCSK9 (Evolocumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for PCSK9 (Evolocumab Biosimilar) antibodies
This PCSK9 (Evolocumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-PCSK9 (Evolocumab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-PCSK9 Reference Antibody (evolocumab)
Characteristics
Anti-PCSK9 Reference Antibody (evolocumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG2SA
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for PCSK9 (Evolocumab Biosimilar)
(hide)
Target
PCSK9 (Evolocumab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
Q8NBP7
Recently viewed
(hide)
Chat with us , powered by LiveChat